Safety of brand name to generic substitution of lacosamide in patients with epilepsy - A prospective single-center observational study

Magdalena Bosak, Martyna Woźniak, Maciej Kasprzycki, Agnieszka Słowik

Open source

DOI
10.1016/j.seizure.2023.09.001
Published
2023-10
Container
Seizure: European Journal of Epilepsy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.seizure.2023.09.001,
  title = {Safety of brand name to generic substitution of lacosamide in patients with epilepsy - A prospective single-center observational study},
  author = {Magdalena Bosak and Martyna Woźniak and Maciej Kasprzycki and Agnieszka Słowik},
  year = {2023},
  journal = {Seizure: European Journal of Epilepsy},
  doi = {10.1016/j.seizure.2023.09.001},
  url = {https://doi.org/10.1016/j.seizure.2023.09.001}
}

RIS

TY  - JOUR
TI  - Safety of brand name to generic substitution of lacosamide in patients with epilepsy - A prospective single-center observational study
AU  - Magdalena Bosak
AU  - Martyna Woźniak
AU  - Maciej Kasprzycki
AU  - Agnieszka Słowik
PY  - 2023
JO  - Seizure: European Journal of Epilepsy
DO  - 10.1016/j.seizure.2023.09.001
UR  - https://doi.org/10.1016/j.seizure.2023.09.001
ER  - 

APA

Bosak, M., Woźniak, M., Kasprzycki, M., & Słowik, A. (2023). Safety of brand name to generic substitution of lacosamide in patients with epilepsy - A prospective single-center observational study. Seizure: European Journal of Epilepsy. https://doi.org/10.1016/j.seizure.2023.09.001

Source records